Khatu International

CoviRAT is an in­vitro, rapid, qualitative immunoassay for the detection of nucleocapsid protein antigens expressed by the SARS­CoV­2 virus present in human nasopharyngeal swab specimen. It is to be used for screening or to aid in the diagnosis of COVID­19 and takes 15­30 minutes for producing test result. Rapid antigen tests are known to be sensitive enough to detect clinical cases, i.e. presymptomatic and early symptomatic cases (up to five days from symptom onset; or low RT­PCR cycle threshold (Ct) value <30), which likely account for a significant proportion of transmissions. The use of sensitive and specific rapid antigen test is appropriate in high prevalence areas as well as in low prevalence areas to identify the infectious positive cases. Rapid antigen tests can help reduce further transmission through early identification of positive cases, enabling a faster contact tracing. Double Antibody Sandwich Assay. Monoclonal antibodies used in both capture and tracer part. Nasopharyngeal specimen can be used. Rapid Antigen Detection Test. Sterile Breakable nasopharyngeal swabs. Sensitivity 96.3%* Specificity 100% Detects nucleocapsid protein antigens expressed by SARS­CoV­2 virus. Ensures specific detection and timely isolation of the infected person. 

Personal Protective Equipment (PPE) is specialized clothing or equipment worn by an employee for protection against infectious materials.

PPE prevents contact with an infectious agent or body fluid that may contain an infectious agent, by creating a barrier between the potential infectious material and the health care worker.